g-NK cells from umbilical cord blood are phenotypically and functionally different than g-NK cells from peripheral blood

References

• Wolf NK, Kissiov DU, Raulet DH. Roles of natural killer cells in immunity to cancer, and applications to immunotherapy. Nat Rev Immunol. 2022;23(2):90–11. doi:10.1038/s41577-022-00732-1.
   PubMed Web of Science ®Google Scholar
• Biron CA, Byron KS, Sullivan JL. Severe herpesvirus infections in an adolescent without natural killer cells. N Engl J Med. 1989;320(26):1731–1735. doi:10.1056/NEJM198906293202605.
   PubMed Web of Science ®Google Scholar
• Shang QN, Yu XX, Xu ZL, Chen YH, Han TT, Zhang YY, Lv M, Sun YQ, Wang Y, Xu LP, et al. Expanded clinical-grade NK cells exhibit stronger effects than primary NK cells against HCMV infection. Cell Mol Immunol. 2023;20(8):895–907. doi:10.1038/s41423-023-01046-5.
   PubMed Web of Science ®Google Scholar
• Fowler K, Mucha J, Neumann M, Lewandowski W, Kaczanowska M, Grys M, Schmidt E, Natenshon A, Talarico C, Buck PO, et al. A systematic literature review of the global seroprevalence of cytomegalovirus: possible implications for treatment, screening, and vaccine development. BMC Publ Health. 2022;22(1):1659. doi:10.1186/s12889-022-13971-7.
   PubMed Web of Science ®Google Scholar
• Zhang T, Scott JM, Hwang I, Kim S. Cutting edge: antibody-dependent memory-like NK cells distinguished by FcRgamma deficiency. J Immunol. 2013;190(4):1402–1406. doi:10.4049/jimmunol.1203034.
   PubMed Web of Science ®Google Scholar
• Muntasell A, Pupuleku A, Cisneros E, Vera A, Moraru M, Vilches C, López-Botet M. Relationship of NKG2C copy number with the distribution of distinct cytomegalovirus-induced adaptive NK cell subsets. J Immunol. 2016;196(9):3818–3827. doi:10.4049/jimmunol.1502438.
   PubMed Web of Science ®Google Scholar
• Ruckert T, Lareau CA, Mashreghi MF, Ludwig LS, Romagnani C. Clonal expansion and epigenetic inheritance of long-lasting NK cell memory. Nat Immunol. 2022;23(11):1551–1563. doi:10.1038/s41590-022-01327-7.
   PubMed Web of Science ®Google Scholar
• Schlums H, Cichocki F, Tesi B, Theorell J, Beziat V, Holmes T, Han H, Chiang SC, Foley B, Mattsson K, et al. Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector function. Immunity. 2015;42(3):443–456. doi:10.1016/j.immuni.2015.02.008.
   PubMed Web of Science ®Google Scholar
• Bjorkstrom NK, Ljunggren HG, Michaelsson J. Emerging insights into natural killer cells in human peripheral tissues. Nat Rev Immunol. 2016;16(5):310–320. doi:10.1038/nri.2016.34.
   PubMed Web of Science ®Google Scholar
• Haroun-Izquierdo A, Vincenti M, Netskar H, van Ooijen H, Zhang B, Bendzick L, Kanaya M, Momayyezi P, Li S, Wiiger MT, et al. Adaptive single-KIR +NKG2C+ NK cells expanded from select superdonors show potent missing-self reactivity and efficiently control HLA-mismatched acute myeloid leukemia. J Immunother Cancer. 2022;10(11):e005577. doi:10.1136/jitc-2022-005577.
   PubMed Web of Science ®Google Scholar
• Lee J, Zhang T, Hwang I, Kim A, Nitschke L, Kim M, Scott J, Kamimura Y, Lanier L, Kim S, et al. Epigenetic modification and antibody-dependent expansion of memory-like NK cells in human cytomegalovirus-infected individuals. Immunity. 2015;42(3):431–442. doi:10.1016/j.immuni.2015.02.013.
   PubMed Web of Science ®Google Scholar
• Hwang I, Zhang T, Scott JM, Kim AR, Lee T, Kakarla T, Kim A, Sunwoo JB, Kim S. Identification of human NK cells that are deficient for signaling adaptor FcR and specialized for antibody-dependent immune functions. Int Immunol. 2012;24(12):793–802. doi:10.1093/intimm/dxs080.
   PubMed Web of Science ®Google Scholar
• Forrest C, Chase TJG, Cuff AO, Maroulis D, Motallebzadeh R, Gander A, Davidson B, Griffiths P, Male V, Reeves M, et al. Control of human cytomegalovirus replication by liver resident natural killer cells. Nat Commun. 2023;14(1):1409. doi:10.1038/s41467-023-37181-w.
   PubMed Web of Science ®Google Scholar
• Davis NL, King CC, Kourtis AP. Cytomegalovirus infection in pregnancy. Birth Defects Res. 2017;109(5):336–346. doi:10.1002/bdra.23601.
   PubMed Web of Science ®Google Scholar
• Baek HJ, Kim DW, Phan MT, Kim JS, Yang JH, Choi JI, Lee JJ, Shin MG, Ryang DW, Kim SK, et al. Comparison of FcRγ-deficient and CD57+ natural killer cells between cord blood and adult blood in the cytomegalovirus-endemic Korean population. Ann Lab Med. 2015;35(4):423–428. doi:10.3343/alm.2015.35.4.423.
   PubMed Web of Science ®Google Scholar
• Liu W. Evaluating human natural killer cells antibody-dependent cellular cytotoxicity (ADCC) using plate-bound anti-CD16 antibodies. Bio-protocol. 2022;12(1):e4285. doi:10.21769/BioProtoc.4285.
   PubMedGoogle Scholar
• Moore GL, Chen H, Karki S, Lazar GA. Engineered Fc variant antibodies with enhanced ability to recruit complement and mediate effector functions. MAbs. 2010;2(2):181–189. doi:10.4161/mabs.2.2.11158.
   PubMed Web of Science ®Google Scholar
• Djaoud Z, Parham P. Hlas, TCRs, and KIRs, a triumvirate of human cell-mediated immunity. Annu Rev Biochem. 2020;89(1):717–739. doi:10.1146/annurev-biochem-011520-102754.
   PubMedGoogle Scholar
• Shemesh A, Su Y, Calabrese DR, Chen D, Arakawa-Hoyt J, Roybal KT, Heath JR, Greenland JR, Lanier LL. Diminished cell proliferation promotes natural killer cell adaptive-like phenotype by limiting FcεRIγ expression. J Exp Med. 2022;219(11): doi:10.1084/jem.20220551.
   Web of Science ®Google Scholar
• Sanchez-Martinez D, Allende-Vega N, Orecchioni S, Talarico G, Cornillon A, Vo DN, Rene C, Lu ZY, Krzywinska E, Anel A, et al. Expansion of allogeneic NK cells with efficient antibody-dependent cell cytotoxicity against multiple tumors. Theranostics. 2018;8(14):3856–3869. doi:10.7150/thno.25149.
   PubMed Web of Science ®Google Scholar
• Foley B, Cooley S, Verneris MR, Curtsinger J, Luo X, Waller EK, Anasetti C, Weisdorf D, Miller JS. Human cytomegalovirus (CMV)-induced memory-like NKG2C+ NK cells are transplantable and expand In vivo in response to recipient CMV antigen. J Immunol. 2012;189(10):5082–5088. doi:10.4049/jimmunol.1201964.
   PubMed Web of Science ®Google Scholar
• Lopez-Botet M, De Maria A, Muntasell A, Della Chiesa M, Vilches C. Adaptive NK cell response to human cytomegalovirus: facts and open issues. Semin Immunol. 2023;65:101706. doi:10.1016/j.smim.2022.101706.
   PubMed Web of Science ®Google Scholar
• Guma M, Angulo A, Vilches C, Gómez-Lozano N, Malats N, López-Botet M. Imprint of human cytomegalovirus infection on the NK cell receptor repertoire. Blood. 2004;104(12):3664–3671. doi:10.1182/blood-2004-05-2058.
   PubMed Web of Science ®Google Scholar
• Lee J, Chang WLW, Scott JM, Hong S, Lee T, Deere JD, Park PH, Sparger EE, Dandekar S, Hartigan-O’Connor DJ, et al. FcRgamma- NK cell induction by specific cytomegalovirus and expansion by subclinical viral infections in rhesus macaques. J Immunol. 2023;211(3):443–452.
   PubMedGoogle Scholar
• Lee J, Kim S, Scott J, Al-Homsi AS, Williams SF, Muilenburg M, Hong S, Esselman WJ. Formation of FcRγ-deficient NK cell subset associated with HCMV-reactivation in hematopoietic cell transplant recipients. JCO. 2017;35(7_suppl):131–131. doi:10.1200/JCO.2017.35.7_suppl.131.
   PubMed Web of Science ®Google Scholar
• Guma M, Budt M, Sáez A, Brckalo T, Hengel H, Angulo A, López-Botet M. Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts. Blood. 2006;107(9):3624–3631. doi:10.1182/blood-2005-09-3682.
   PubMed Web of Science ®Google Scholar
• Semmes EC, Miller IG, Rodgers N, Phan CT, Hurst JH, Walsh KM, Stanton RJ, Pollara J, Permar SR. ADCC-activating antibodies correlate with decreased risk of congenital human cytomegalovirus transmission. JCI Insight. 2023;8(13): doi:10.1172/jci.insight.167768.
   PubMed Web of Science ®Google Scholar
• Semmes EC, Nettere DR, Nelson AN, Hurst JH, Cain D, Burt TD, Kurtzberg J, Reeves RK, Coyne CB, Fouda GG, et al. In utero human cytomegalovirus infection expands NK cell-like FcgammaRIII-expressing CD8+ T cells that mediate antibody-dependent functions. medRxiv. 2023. doi:10.1101/2023.09.08.23295279.
   Google Scholar
• Hammer Q, Ruckert T, Borst EM, Dunst J, Haubner A, Durek P, Heinrich F, Gasparoni G, Babic M, Tomic A, et al. Peptide-specific recognition of human cytomegalovirus strains controls adaptive natural killer cells. Nat Immunol. 2018;19(5):453–463. doi:10.1038/s41590-018-0082-6.
   PubMed Web of Science ®Google Scholar
• Liu LL, Landskron J, Ask EH, Enqvist M, Sohlberg E, Traherne JA, Hammer Q, Goodridge JP, Larsson S, Jayaraman J, et al. Critical role of CD2 co-stimulation in adaptive natural killer cell responses revealed in NKG2C-deficient humans. Cell Rep. 2016;15(5):1088–1099. doi:10.1016/j.celrep.2016.04.005.
   PubMed Web of Science ®Google Scholar
• Manser AR, Scherenschlich N, Thons C, Hengel H, Timm J, Uhrberg M. KIR polymorphism modulates the size of the adaptive NK cell pool in human cytomegalovirus–infected individuals. J Immunol. 2019;203(8):2301–2309. doi:10.4049/jimmunol.1900423.
   PubMed Web of Science ®Google Scholar
• Zuo W, Yu XX, Liu XF, Chang YJ, Wang Y, Zhang XH, Xu LP, Liu KY, Zhao XS, Huang X, et al. The interaction of HLA-C1/KIR2DL2/L3 promoted KIR2DL2/L3 single-positive/NKG2C-Positive natural killer cell reconstitution, raising the incidence of aGVHD after hematopoietic stem cell transplantation. Front Immunol. 2022;13:814334. doi:10.3389/fimmu.2022.814334.
   PubMed Web of Science ®Google Scholar
• Lopez-Verges S, Milush JM, Schwartz BS, Pando MJ, Jarjoura J, York VA, Houchins JP, Miller S, Kang SM, Norris PJ, et al. Expansion of a unique CD57 + NKG2C hi natural killer cell subset during acute human cytomegalovirus infection. Proc Natl Acad Sci USA. 2011;108(36):14725–14732. doi:10.1073/pnas.1110900108.
   PubMed Web of Science ®Google Scholar
• Dahlvang JD, Dick JK, Sangala JA, Kennedy PR, Pomeroy EJ, Snyder KM, Moushon JM, Thefaine CE, Wu J, Hamilton SE, et al. Ablation of SYK kinase from expanded primary human NK cells via CRISPR/Cas9 enhances cytotoxicity and cytokine production. J Immunol. 2023;210(8):1108–1122. doi:10.4049/jimmunol.2200488.
   PubMed Web of Science ®Google Scholar
• Zhou J, Amran FS, Kramski M, Angelovich TA, Elliott J, Hearps AC, Price P, Jaworowski A. An NK cell population lacking FcRγ is expanded in chronically infected HIV patients. J Immunol. 2015;194(10):4688–4697. doi:10.4049/jimmunol.1402448.
   PubMed Web of Science ®Google Scholar